COST-EFFECTIVENESS OF CARDIAC RESYNCHRONISATION THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE HEART FAILURE

被引：0
|
作者：
Neyt, M. [1 ]
Stroobandt, S. [1 ]
Obyn, C. [1 ]
Camberlin, C. [1 ]
Devriese, S. [1 ]
De Laet, C. [1 ]
Van Brabandt, H. [1 ]
机构：
[1] Belgian Hlth Care Knowledge Ctr, Brussels, Belgium
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.121
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A253 / A253
页数：1
相关论文
共 50 条
  • [41] Cardiac resynchronisation therapy for heart failure
    Behan, M. W. H.
    Rinaldi, C. A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (09) : 1107 - 1114
  • [42] Cardiac resynchronisation therapy for heart failure
    Mariani, JA
    Gould, PA
    Broughton, A
    Kaye, DM
    INTERNAL MEDICINE JOURNAL, 2006, 36 (02) : 114 - 123
  • [43] Cardiac resynchronisation therapy for heart failure
    Behan, M. W. H.
    Rinaldi, C. A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (02) : 349 - 349
  • [44] Cardiac Resynchronisation Therapy in Heart Failure
    Wahab, Arif
    Alvi, Shaista
    Panwar, Raja B.
    Gavade, Sachin R.
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2011, 5 (04) : 121 - 126
  • [45] Cost-effectiveness of cardiac-resynchronization therapy with and without a defibrillator in COMPANION heart failure patients
    Feldman, AM
    de Lissovoy, G
    Bristow, MR
    Saxon, LA
    De Marco, T
    Kass, DA
    Boehmer, J
    Singh, S
    Whellan, DJ
    Carson, P
    Boscoe, A
    Baker, T
    Gunderman, MR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 160A - 160A
  • [46] COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN
    Menchen, L.
    de Andres-Nogales, F.
    Garcia, S.
    Sanchez-Guerrero, A.
    Menchen, B.
    Cabez, A.
    Gomez, S.
    Lopez, A.
    Casado, M. A.
    Peral, C.
    Taxonera, C.
    VALUE IN HEALTH, 2019, 22 : S619 - S619
  • [47] Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
    Mealing, Stuart
    Woods, Beth
    Hawkins, Neil
    Cowie, Martin R.
    Plummer, Christopher J.
    Abraham, William T.
    Beshai, John F.
    Klein, Helmut
    Sculpher, Mark
    HEART, 2016, 102 (21) : 1742 - 1749
  • [48] Cost-effectiveness of tildrakizumab in U. S. patients with moderate-to-severe plaque psoriasis
    Jia, Xiaoying
    Zhao, Yang
    Carrico, Justin
    Brodtkorb, Thor-Henrik
    Mendelsohn, Alan
    Lowry, Simon
    Feldman, Steve R.
    Wu, Jashin J.
    Armstrong, April
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB39 - AB39
  • [49] Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
    Li, SiNi
    Li, JianHe
    Peng, LiuBao
    Li, YaMin
    Wan, XiaoMin
    RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 863 - 876
  • [50] Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
    SiNi Li
    JianHe Li
    LiuBao Peng
    YaMin Li
    XiaoMin Wan
    Rheumatology and Therapy, 2021, 8 : 863 - 876
12345